FI963566A - Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa - Google Patents
Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa Download PDFInfo
- Publication number
- FI963566A FI963566A FI963566A FI963566A FI963566A FI 963566 A FI963566 A FI 963566A FI 963566 A FI963566 A FI 963566A FI 963566 A FI963566 A FI 963566A FI 963566 A FI963566 A FI 963566A
- Authority
- FI
- Finland
- Prior art keywords
- processes
- preparation
- compositions containing
- piperazine derivatives
- new piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19950000399 | 1995-01-11 | ||
| KR1019950043607A KR0162710B1 (ko) | 1995-01-10 | 1995-11-24 | 신규 피페라진 유도체 및 그 제조방법 |
| PCT/KR1996/000005 WO1996021648A1 (en) | 1995-01-11 | 1996-01-10 | New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI963566A0 FI963566A0 (sv) | 1996-09-10 |
| FI963566A true FI963566A (sv) | 1996-09-10 |
Family
ID=26630862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI963566A FI963566A (sv) | 1995-01-11 | 1996-09-10 | Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5780472A (sv) |
| EP (1) | EP0749425A1 (sv) |
| JP (1) | JP2978967B2 (sv) |
| CN (1) | CN1128139C (sv) |
| AU (1) | AU699619B2 (sv) |
| BR (1) | BR9605309A (sv) |
| CA (1) | CA2184919C (sv) |
| CZ (1) | CZ288002B6 (sv) |
| FI (1) | FI963566A (sv) |
| HU (1) | HUP9602489A3 (sv) |
| NO (1) | NO307459B1 (sv) |
| NZ (1) | NZ298499A (sv) |
| PL (1) | PL183865B1 (sv) |
| RO (1) | RO115159B1 (sv) |
| SK (1) | SK282252B6 (sv) |
| WO (1) | WO1996021648A1 (sv) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6048876A (en) * | 1995-01-23 | 2000-04-11 | Suntory Limited | Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor |
| RU2146254C1 (ru) * | 1996-06-29 | 2000-03-10 | Самдзин Фармасьютикал Ко., Лтд. | Производные пиперазина и способ их получения |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| US6794392B1 (en) | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
| KR100420616B1 (ko) * | 1996-12-26 | 2004-05-17 | 동화약품공업주식회사 | 신규테레프탈산아미드유도체 |
| ES2300151T3 (es) | 1998-09-22 | 2008-06-01 | Astellas Pharma Inc. | Derivados de cianofenilo. |
| EP1075469B1 (en) * | 1999-03-03 | 2004-05-26 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
| AU8066701A (en) | 2000-07-20 | 2002-02-05 | Neurogen Corp | Capsaicin receptor ligands |
| DE10035908A1 (de) | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
| AU2002344951A1 (en) * | 2001-07-02 | 2003-01-21 | Boehringer Ingelheim International Gmbh | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| IL160974A0 (en) * | 2001-10-22 | 2004-08-31 | Pfizer Prod Inc | Piperazine derivatives with ccr1 receptor antagonist activity |
| JP2005518377A (ja) * | 2001-12-14 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | ホルモン感受性リパーゼの活性を低下させるための化合物の使用 |
| EP2033951A3 (en) | 2002-02-01 | 2009-12-23 | Euro-Celtique S.A. | 2-Piperazine-pyridines useful for treating pain |
| DK1556354T3 (da) | 2002-06-28 | 2008-06-02 | Euro Celtique Sa | Terapeutiske piperazinderivater, der er egnede til behandling af smerter |
| US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| WO2004083235A2 (en) * | 2003-03-19 | 2004-09-30 | Exelixis Inc. | Tie-2 modulators and methods of use |
| KR101287955B1 (ko) * | 2004-12-30 | 2013-07-23 | 얀센 파마슈티카 엔.브이. | 지방산 아미드 하이드롤라제의 조정자로서 피페라지닐 및피페리디닐 우레아 |
| KR101065979B1 (ko) | 2005-02-17 | 2011-09-19 | 아스텔라스세이야쿠 가부시키가이샤 | 피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르 유도체 |
| WO2007005510A1 (en) | 2005-06-30 | 2007-01-11 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| EP1923388A4 (en) | 2005-08-12 | 2011-03-09 | Takeda Pharmaceutical | BRAIN / NERVE CELL PROTECTION AND THERAPEUTIC FOR SLEEP DISORDERS |
| CA2663984C (en) | 2006-10-18 | 2012-02-21 | Pfizer Products Inc. | Biaryl ether urea compounds |
| BRPI0813331A2 (pt) * | 2007-06-08 | 2014-12-23 | Janssen Pharmaceutica Nv | Derivados de piperidina/piperazina |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| ES2483898T3 (es) | 2007-06-08 | 2014-08-08 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| ES2558152T3 (es) | 2007-06-08 | 2016-02-02 | Janssen Pharmaceutica, N.V. | Derivados de piperidina/piperazina |
| TW200924778A (en) * | 2007-10-10 | 2009-06-16 | Takeda Pharmaceutical | Amide compound |
| PE20140572A1 (es) | 2008-06-05 | 2014-05-16 | Janssen Pharmaceutica Nv | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar |
| WO2011060026A1 (en) | 2009-11-12 | 2011-05-19 | Jansen Pharmaceutica Nv | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| EP3373935B1 (en) * | 2015-11-12 | 2021-09-01 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| MA46589A (fr) * | 2016-10-24 | 2019-08-28 | Yumanity Therapeutics Inc | Composés et utilisations de ces derniers |
| US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| EP3914593A4 (en) | 2019-01-24 | 2022-11-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND THEIR USES |
| JPWO2022118966A1 (sv) * | 2020-12-04 | 2022-06-09 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
| AU7580187A (en) * | 1986-06-23 | 1988-01-12 | Upjohn Company, The | Androstane-type and cortical aminoesters |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| JPH02142770A (ja) * | 1988-11-25 | 1990-05-31 | Shigeki Shin | ピペラジン系誘導体 |
| JPH03141258A (ja) * | 1989-10-25 | 1991-06-17 | Kowa Co | 新規なピペラジン誘導体 |
| DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
-
1996
- 1996-01-10 BR BR9605309A patent/BR9605309A/pt unknown
- 1996-01-10 HU HU9602489A patent/HUP9602489A3/hu unknown
- 1996-01-10 EP EP96900459A patent/EP0749425A1/en not_active Withdrawn
- 1996-01-10 CZ CZ19962960A patent/CZ288002B6/cs not_active IP Right Cessation
- 1996-01-10 US US08/676,174 patent/US5780472A/en not_active Expired - Lifetime
- 1996-01-10 PL PL96316613A patent/PL183865B1/pl unknown
- 1996-01-10 AU AU44007/96A patent/AU699619B2/en not_active Expired
- 1996-01-10 WO PCT/KR1996/000005 patent/WO1996021648A1/en not_active Application Discontinuation
- 1996-01-10 SK SK889-96A patent/SK282252B6/sk unknown
- 1996-01-10 CA CA002184919A patent/CA2184919C/en not_active Expired - Lifetime
- 1996-01-10 JP JP8521570A patent/JP2978967B2/ja not_active Expired - Lifetime
- 1996-01-10 NZ NZ298499A patent/NZ298499A/en not_active IP Right Cessation
- 1996-01-10 RO RO96-01781A patent/RO115159B1/ro unknown
- 1996-01-10 CN CN96190006A patent/CN1128139C/zh not_active Expired - Lifetime
- 1996-09-10 FI FI963566A patent/FI963566A/sv unknown
- 1996-09-10 NO NO963792A patent/NO307459B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2184919C (en) | 2000-03-14 |
| FI963566A0 (sv) | 1996-09-10 |
| SK282252B6 (sk) | 2001-12-03 |
| AU4400796A (en) | 1996-07-31 |
| AU699619B2 (en) | 1998-12-10 |
| CZ288002B6 (cs) | 2001-03-14 |
| CN1145620A (zh) | 1997-03-19 |
| HUP9602489A2 (en) | 1997-08-28 |
| SK88996A3 (en) | 1997-05-07 |
| EP0749425A1 (en) | 1996-12-27 |
| RO115159B1 (ro) | 1999-11-30 |
| PL183865B1 (pl) | 2002-07-31 |
| HU9602489D0 (en) | 1996-11-28 |
| WO1996021648A1 (en) | 1996-07-18 |
| CA2184919A1 (en) | 1996-07-18 |
| NO963792D0 (no) | 1996-09-10 |
| PL316613A1 (en) | 1997-01-20 |
| NO963792L (no) | 1996-11-11 |
| JP2978967B2 (ja) | 1999-11-15 |
| NO307459B1 (no) | 2000-04-10 |
| NZ298499A (en) | 1998-01-26 |
| CN1128139C (zh) | 2003-11-19 |
| JPH09511764A (ja) | 1997-11-25 |
| US5780472A (en) | 1998-07-14 |
| CZ296096A3 (en) | 1997-02-12 |
| BR9605309A (pt) | 1997-10-14 |
| HUP9602489A3 (en) | 1998-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI963566A (sv) | Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa | |
| FI973039A (sv) | Nya farnecyltransferasinhibitorer, deras framställning och dessa innehållande farmaceutiska kompositioner | |
| FI941137A0 (sv) | 2-debensoyl-2-acyltaxolderivat och förfaranden för framställning av dessa | |
| FI973426A (sv) | Benzopyran innehållande föreningar och förfarande för deras framställning | |
| IL118369A0 (en) | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| FI945731A (sv) | Tiazolidinderivat och farmaceutiska sammansättningar innehållande dem | |
| FI972646A (sv) | Piperazinderivat, dessa föreningar innehållande läkemedel, deras användning och förfarande för deras framställning | |
| FI962445A (sv) | Paroxetintabletter och förfarande för framställning av dem | |
| IL119778A (en) | Neuropretective pharmaceutical compositions containing rapamycin derivatives | |
| EE9800426A (et) | Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| FI950625A0 (sv) | Polysubstituerade 3-acylamino-5-fenyl-1,4-bensodiazepin-2-on derivat, förfarande för framställning av dessa och farmaceutiska kompositioner innehållande dessa | |
| FI943645A0 (sv) | Nya backatin-III och 10-deacetylbackatin-III-derivat, framställning av dem och dessa innehållande farmaceutiska kompositioner | |
| FI945780A0 (sv) | Nya biologiskt aktiva eburnameninderivat, farmaceutiska kompositioner innehållande dessa och förfarande för framställning av dessa | |
| IL118427A (en) | N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them | |
| FI940775A (sv) | Förfarande för framställning av alfa-fenylisoserinderivat och användning av dem | |
| IL123900A0 (en) | New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions | |
| EE03395B1 (et) | Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised | |
| EE9900426A (et) | Püridiini uued derivaadid ja neid sisaldavad ravimkoostised | |
| FI972306A (sv) | Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning | |
| EE03611B1 (et) | Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE9900206A (et) | N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid | |
| FI942222A (sv) | Förfarande för framställning av torrbehandlade partiklar, så erhållna torrbehandlade partiklar och farmaceutiska kompositioner innehållande dessa | |
| FI964900A (sv) | Nya taxoider, deras framställning och dessa innehållande farmaceutiska kompositioner | |
| FI950874A0 (sv) | Nya polyjodiserade föreningar, förfarande för framställning av dem och dessa innehållande kontrastmedel | |
| EE9900435A (et) | Püridiini uued derivaadid ja neid sisaldavad ravimkoostised |